Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Non-Current Assets (2019 - 2025)

Biodesix's Other Non-Current Assets history spans 7 years, with the latest figure at $8.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 13.36% year-over-year to $8.2 million; the TTM value through Dec 2025 reached $8.2 million, up 13.36%, while the annual FY2025 figure was $8.2 million, 13.36% up from the prior year.
  • Other Non-Current Assets reached $8.2 million in Q4 2025 per BDSX's latest filing, up from $7.5 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $8.2 million in Q4 2025 to a low of $5100.0 in Q2 2022.
  • Average Other Non-Current Assets over 5 years is $5.4 million, with a median of $6.5 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: tumbled 99.8% in 2022, then skyrocketed 136919.61% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $1.7 million in 2021, then soared by 257.45% to $5.9 million in 2022, then grew by 15.8% to $6.9 million in 2023, then increased by 5.85% to $7.3 million in 2024, then rose by 13.36% to $8.2 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Other Non-Current Assets are $8.2 million (Q4 2025), $7.5 million (Q3 2025), and $7.2 million (Q2 2025).